论文部分内容阅读
目的探讨康复新液、喜炎平联合利巴韦林治疗小儿手足口病的临床疗效。方法选取2015年1月—2016年2月该院患者120例,按照随机平分为对照组和研究组,每组60例,对照组患者采取利巴韦林治疗;研究组在对照组治疗的基础上引入喜炎平和康复新液进行联合治疗。结果研究组的有效率为96.73%明显好于对照组的72.59%;患儿食欲好转时间、疱疹消失时间、退热时间和治愈时间方面,研究组明显好于对照组;患儿的不良反应症状,研究组好于对照组,差异有统计学意义(P<0.05)。结论在临床治疗小儿手足口病方面采用康复新液、喜炎平和利巴韦林联合治疗,效果好,不良反应少,安全性高,可以临床推广。
Objective To investigate the clinical effects of Kangfuxin and Xiyanping combined with ribavirin in the treatment of hand-foot-mouth disease in children. Methods 120 patients in our hospital from January 2015 to February 2016 were randomly divided into control group and study group, 60 cases in each group. The control group was treated with ribavirin. The basis of the study group in the control group On the introduction of Xi Yan Ping and rehabilitation of new liquid for joint treatment. Results The effective rate of the study group was 96.73%, which was significantly better than that of the control group (72.59%). The improvement time of appetite, disappearance of herpes, antipyretic time and cure time in the study group were significantly better than those in the control group. The adverse reaction symptoms , The study group was better than the control group, the difference was statistically significant (P <0.05). Conclusions In the clinical treatment of children with hand-foot-mouth disease, Kangfuxin solution, xiyanping and ribavirin combination therapy, the effect is good, less adverse reactions, high safety, and can be clinically promoted.